Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Authors / William Aryitey

William Aryitey

My fascination with science, gaming, and writing led to my studying biology at university, while simultaneously working as an online games journalist. After university, I travelled across Europe, working on a novel and developing a game, before finding my way to Texere. As Associate Editor, I’m evolving my loves of science and writing, while continuing to pursue my passion for gaming and creative writing in a personal capacity.

  • Contributions

Business-in-Brief

November 22, 2017

Expediting generics, the age of digital manufacture, and coping with API violations… What’s new for pharma in business?

1 min read

Business-in-Brief

Steady On, Pharma

November 22, 2017

Pharma’s 2022 growth forecast has been reduced for the first time in a decade

1 min read

Steady On, Pharma

Mini Mimic

November 22, 2017

Body-on-a-chip technology aims to streamline drug development and further personalize medicine

1 min read

Learning from Failure

November 22, 2017

Cardiovascular toxicity often hinders success – are companies picking the wrong compounds?

1 min read

Learning from Failure

The FDA Abroad

November 24, 2017

FDA partners with EU authorities for pharma inspections

1 min read

The FDA Abroad

IP Deal or No Deal?

October 13, 2017

The future status of pharma intellectual property in the UK depends on the outcome of Brexit

1 min read

IP Deal or No Deal?

Skin in the Game

October 13, 2017

Could donated skin be a viable alternative to animal testing?

1 min read

Skin in the Game

Business-in-Brief

October 13, 2017

Record generic approvals, a joint opioid investigation, and emerging technology guidance... What’s new for pharma in business?

1 min read

Business-in-Brief

An All-in-One Vaccine

October 16, 2017

Can microparticles make it possible to administer multiple drugs and vaccines in a single injection?

1 min read

An All-in-One Vaccine

Making Therapeutic History

September 20, 2017

The wait is over: the FDA gives a ‘thumbs-up’ to the first CAR-T therapy

1 min read

Making Therapeutic History

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.